Successful Treatment of Prosthetic Joint Infection due to Vancomycin-resistant Enterococci with Tedizolid
Sheng Si, Michael J Durkin, Maureen M Mercier, Melanie L Yarbrough, Stephen Y Liang, Sheng Si, Michael J Durkin, Maureen M Mercier, Melanie L Yarbrough, Stephen Y Liang
Abstract
Few antibiotic options exist for the management of infections due to vancomycin-resistant enterococci (VRE). We describe a case involving the safe and successful use of tedizolid, a new oxazolidinone, to treat VRE prosthetic joint infection.
Keywords: prosthetic joint infection; tedizolid; vancomycin-resistant enterococci.
Conflict of interest statement
Potential conflicts of interest: S.Y.L. serves as a sub-investigator for institutional research studies sponsored by Cepheid. M.J.D. has received royalties for the development of education materials for Medscape, funded in part by Merck. S.S., M.L.Y., and M.M.M. have no reported conflicts.
Figures
Source: PubMed